Status iFOBT
For the Qualitative Detection of Immunochemical Fecal Occult Blood
(Human Hemoglobin in Human Fecal Specimens)
CLIA Waived
Superior sensitivity and specificity
Human hemoglobin specific for reducing false positives
Easy one-step test procedure
Specimen can be collected in office or at home
Patient friendly and easy-to-follow instructions
Non-invasive collection method
Only one test device needed
No dietary or drug restrictions for iFOBT
Country Of Origin
United States
Manufacturer
Lifesign
Number Of Tests
30 Tests
Sold By
Box of 30
Test Type
Colorectal Cancer Screening
Time to Results
5 to 10 Min
Can the fecal occult status iFOBT test be reliably used in an at-home setting without professional supervision?
Yes, the fecal occult status iFOBT test is designed for ease of use in both clinical and at-home settings, with patient-friendly instructions that support unsupervised use [Manufacturer Info].
How does the specificity of this test for human hemoglobin help reduce false positives compared to other fecal occult blood tests?
This test's specificity for human hemoglobin targets only relevant blood sources, significantly reducing false positives that may occur from non-human hemoglobin sources [Manufacturer Info].
What steps should clinicians follow to ensure accurate results when using this test in a healthcare setting?
Clinicians should follow the easy one-step test procedure, ensure proper specimen collection, and adhere to the 5 to 10 minute result interpretation time to ensure accuracy [Product Specs][Manufacturer Info].
Are there any particular patient populations for whom this test may be less effective or inappropriate?
The test is generally suitable for broad use, but effectiveness may vary in populations with specific gastrointestinal disorders; professional consultation is recommended [Manufacturer Info].
How quickly can the results be interpreted once the test is performed, and does this time vary significantly with specimen type?
Results can be interpreted within 5 to 10 minutes, and this timing does not vary significantly with specimen type, ensuring consistent performance across different conditions [Product Specs].
What makes this test a more patient-friendly option for early colorectal cancer screening?
Its non-invasive collection method, lack of dietary or drug restrictions, and simple instructions make it a more patient-friendly option for early colorectal cancer screening [Manufacturer Info].
In what ways does the lack of dietary or drug restrictions benefit the accuracy and convenience of this test?
The lack of dietary or drug restrictions prevents interference with test results and simplifies the process for patients, enhancing both accuracy and convenience [Manufacturer Info].
Does the test require any special storage conditions that should be considered during procurement?
No special storage conditions are documented; however, standard medical product storage practices should be followed, such as keeping the tests in a cool, dry place [Industry Standards].
What potential issues might arise when using this test in a high-volume clinical environment, and how can they be mitigated?
Potential issues include logistical challenges in managing large test volumes; these can be mitigated by streamlining procurement and establishing efficient workflow protocols [Industry Standards].
LifesignItem # Dealmed item number: 380305MPN Manufacturer part number: 38030-DTM
Status iFOBT
For the Qualitative Detection of Immunochemical Fecal Occult Blood
(Human Hemoglobin in Human Fecal Specimens)
CLIA Waived
Superior sensitivity and specificity
Human hemoglobin specific for reducing false positives
Easy one-step test procedure
Specimen can be collected in office or at home
Patient friendly and easy-to-follow instructions
Non-invasive collection method
Only one test device needed
No dietary or drug restrictions for iFOBT
Country Of Origin
United States
Manufacturer
Lifesign
Number Of Tests
30 Tests
Sold By
Box of 30
Test Type
Colorectal Cancer Screening
Time to Results
5 to 10 Min
Can the fecal occult status iFOBT test be reliably used in an at-home setting without professional supervision?
Yes, the fecal occult status iFOBT test is designed for ease of use in both clinical and at-home settings, with patient-friendly instructions that support unsupervised use [Manufacturer Info].
How does the specificity of this test for human hemoglobin help reduce false positives compared to other fecal occult blood tests?
This test's specificity for human hemoglobin targets only relevant blood sources, significantly reducing false positives that may occur from non-human hemoglobin sources [Manufacturer Info].
What steps should clinicians follow to ensure accurate results when using this test in a healthcare setting?
Clinicians should follow the easy one-step test procedure, ensure proper specimen collection, and adhere to the 5 to 10 minute result interpretation time to ensure accuracy [Product Specs][Manufacturer Info].
Are there any particular patient populations for whom this test may be less effective or inappropriate?
The test is generally suitable for broad use, but effectiveness may vary in populations with specific gastrointestinal disorders; professional consultation is recommended [Manufacturer Info].
How quickly can the results be interpreted once the test is performed, and does this time vary significantly with specimen type?
Results can be interpreted within 5 to 10 minutes, and this timing does not vary significantly with specimen type, ensuring consistent performance across different conditions [Product Specs].
What makes this test a more patient-friendly option for early colorectal cancer screening?
Its non-invasive collection method, lack of dietary or drug restrictions, and simple instructions make it a more patient-friendly option for early colorectal cancer screening [Manufacturer Info].
In what ways does the lack of dietary or drug restrictions benefit the accuracy and convenience of this test?
The lack of dietary or drug restrictions prevents interference with test results and simplifies the process for patients, enhancing both accuracy and convenience [Manufacturer Info].
Does the test require any special storage conditions that should be considered during procurement?
No special storage conditions are documented; however, standard medical product storage practices should be followed, such as keeping the tests in a cool, dry place [Industry Standards].
What potential issues might arise when using this test in a high-volume clinical environment, and how can they be mitigated?
Potential issues include logistical challenges in managing large test volumes; these can be mitigated by streamlining procurement and establishing efficient workflow protocols [Industry Standards].
Status iFOBT
For the Qualitative Detection of Immunochemical Fecal Occult Blood
(Human Hemoglobin in Human Fecal Specimens)
CLIA Waived
Superior sensitivity and specificity
Human hemoglobin specific for reducing false positives
Easy one-step test procedure
Specimen can be collected in office or at home
Patient friendly and easy-to-follow instructions
Non-invasive collection method
Only one test device needed
No dietary or drug restrictions for iFOBT
Country Of Origin
United States
Manufacturer
Lifesign
Number Of Tests
30 Tests
Sold By
Box of 30
Test Type
Colorectal Cancer Screening
Time to Results
5 to 10 Min
Can the fecal occult status iFOBT test be reliably used in an at-home setting without professional supervision?
Yes, the fecal occult status iFOBT test is designed for ease of use in both clinical and at-home settings, with patient-friendly instructions that support unsupervised use [Manufacturer Info].
How does the specificity of this test for human hemoglobin help reduce false positives compared to other fecal occult blood tests?
This test's specificity for human hemoglobin targets only relevant blood sources, significantly reducing false positives that may occur from non-human hemoglobin sources [Manufacturer Info].
What steps should clinicians follow to ensure accurate results when using this test in a healthcare setting?
Clinicians should follow the easy one-step test procedure, ensure proper specimen collection, and adhere to the 5 to 10 minute result interpretation time to ensure accuracy [Product Specs][Manufacturer Info].
Are there any particular patient populations for whom this test may be less effective or inappropriate?
The test is generally suitable for broad use, but effectiveness may vary in populations with specific gastrointestinal disorders; professional consultation is recommended [Manufacturer Info].
How quickly can the results be interpreted once the test is performed, and does this time vary significantly with specimen type?
Results can be interpreted within 5 to 10 minutes, and this timing does not vary significantly with specimen type, ensuring consistent performance across different conditions [Product Specs].
What makes this test a more patient-friendly option for early colorectal cancer screening?
Its non-invasive collection method, lack of dietary or drug restrictions, and simple instructions make it a more patient-friendly option for early colorectal cancer screening [Manufacturer Info].
In what ways does the lack of dietary or drug restrictions benefit the accuracy and convenience of this test?
The lack of dietary or drug restrictions prevents interference with test results and simplifies the process for patients, enhancing both accuracy and convenience [Manufacturer Info].
Does the test require any special storage conditions that should be considered during procurement?
No special storage conditions are documented; however, standard medical product storage practices should be followed, such as keeping the tests in a cool, dry place [Industry Standards].
What potential issues might arise when using this test in a high-volume clinical environment, and how can they be mitigated?
Potential issues include logistical challenges in managing large test volumes; these can be mitigated by streamlining procurement and establishing efficient workflow protocols [Industry Standards].
Status iFOBT
For the Qualitative Detection of Immunochemical Fecal Occult Blood
(Human Hemoglobin in Human Fecal Specimens)
CLIA Waived
Superior sensitivity and specificity
Human hemoglobin specific for reducing false positives
Easy one-step test procedure
Specimen can be collected in office or at home
Patient friendly and easy-to-follow instructions
Non-invasive collection method
Only one test device needed
No dietary or drug restrictions for iFOBT
Country Of Origin
United States
Manufacturer
Lifesign
Number Of Tests
30 Tests
Sold By
Box of 30
Test Type
Colorectal Cancer Screening
Time to Results
5 to 10 Min
Can the fecal occult status iFOBT test be reliably used in an at-home setting without professional supervision?
Yes, the fecal occult status iFOBT test is designed for ease of use in both clinical and at-home settings, with patient-friendly instructions that support unsupervised use [Manufacturer Info].
How does the specificity of this test for human hemoglobin help reduce false positives compared to other fecal occult blood tests?
This test's specificity for human hemoglobin targets only relevant blood sources, significantly reducing false positives that may occur from non-human hemoglobin sources [Manufacturer Info].
What steps should clinicians follow to ensure accurate results when using this test in a healthcare setting?
Clinicians should follow the easy one-step test procedure, ensure proper specimen collection, and adhere to the 5 to 10 minute result interpretation time to ensure accuracy [Product Specs][Manufacturer Info].
Are there any particular patient populations for whom this test may be less effective or inappropriate?
The test is generally suitable for broad use, but effectiveness may vary in populations with specific gastrointestinal disorders; professional consultation is recommended [Manufacturer Info].
How quickly can the results be interpreted once the test is performed, and does this time vary significantly with specimen type?
Results can be interpreted within 5 to 10 minutes, and this timing does not vary significantly with specimen type, ensuring consistent performance across different conditions [Product Specs].
What makes this test a more patient-friendly option for early colorectal cancer screening?
Its non-invasive collection method, lack of dietary or drug restrictions, and simple instructions make it a more patient-friendly option for early colorectal cancer screening [Manufacturer Info].
In what ways does the lack of dietary or drug restrictions benefit the accuracy and convenience of this test?
The lack of dietary or drug restrictions prevents interference with test results and simplifies the process for patients, enhancing both accuracy and convenience [Manufacturer Info].
Does the test require any special storage conditions that should be considered during procurement?
No special storage conditions are documented; however, standard medical product storage practices should be followed, such as keeping the tests in a cool, dry place [Industry Standards].
What potential issues might arise when using this test in a high-volume clinical environment, and how can they be mitigated?
Potential issues include logistical challenges in managing large test volumes; these can be mitigated by streamlining procurement and establishing efficient workflow protocols [Industry Standards].
:fill(white)/catsy.939/280018_Pro_20Advantage_20Fecal_20Occult_20FOB_20Test_Pro_20Advantage.jpg/rename/280018_Pro_20Advantage_20Fecal_20Occult_20FOB_20Test_Pro_20Advantage.webp)
:fill(white)/catsy.939/Hemocue 60151A.jpg/rename/Hemocue 60151A.webp)
:fill(white)/catsy.939/641510_Fecal_20Occult_20Test_20Hemoccult_20Sensa_20Single_20Slide.jpg/rename/641510_Fecal_20Occult_20Test_20Hemoccult_20Sensa_20Single_20Slide.webp)
:fill(white)/catsy.939/FecaloccultifobtestT1CM50.jpg/rename/FecaloccultifobtestT1CM50.webp)